Mergers & Acquisitions ·
IB Acquisition Corp. entered into definitive agreements to advance its pending business combination with GNQ Insilico…
IBACRIB Acquisition Corp.
IB Acquisition Corp. entered into definitive agreements to advance its pending business combination with GNQ Insilico, Inc., including an amendment to the Business Combination Agreement that removes the minimum cash closing condition and adjusts financing structures. The company secured a $16.47 million initial PIPE investment in senior secured convertible notes, with potential additional closings up to $90 million at a conversion price of $10.00 per share. Additionally, IB Acquisition Corp. established an Equity Purchase Facility providing access to up to $50.0 million in new capital over 36 months, supported by a $675,000 convertible commitment note. The sponsor's lock-up on 610,500 private placement units was also released. IB Acquisition Corp. operates as a blank check company focused on effecting a merger with GNQ Insilico, Inc., a biotechnology firm.